Albany Molecular Research, a global contract research and manufacturing organization, has appointed Vijay Kumar Batra to managing director, AMRI India, effective Jan. 2. Batra will report to Steve Hagen, Ph.D., senior vice president of manufacturing and pharmaceuticals.
"Batra brings a wealth of experience in the Active Pharmaceutical Ingredients (APIs) and intermediates business and he also brings a leadership acumen that helps AMRI continue our plan for growth in the Indian and world markets," said Hagen.
Batra held a number of executive roles with Teva Pharmaceuticals Industries since 2003. Most recently, he was vice chairman and managing director, Teva API India, responsible for R&D and manufacturing of API's and advanced intermediates for the global market. The facilities overseen by Batra had strong compliance records and achieved FDA and other international certifications. Batra also was chairman of Teva API China during his most recent tenure. Previously, Batra was president and director of JK Drugs and Pharmaceuticals and advisor at JK Pharmachem. He also held other roles with Ranbaxy, Kinetics Technology India and Synthetics and Chemicals. Batra also was responsible for drug product manufacturing and was vice chairman of Tevapharm India during his last few years.